These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21217689)

  • 1. Directed evolution of hydrolases for prevention of G-type nerve agent intoxication.
    Gupta RD; Goldsmith M; Ashani Y; Simo Y; Mullokandov G; Bar H; Ben-David M; Leader H; Margalit R; Silman I; Sussman JL; Tawfik DS
    Nat Chem Biol; 2011 Feb; 7(2):120-5. PubMed ID: 21217689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification.
    Goldsmith M; Ashani Y; Simo Y; Ben-David M; Leader H; Silman I; Sussman JL; Tawfik DS
    Chem Biol; 2012 Apr; 19(4):456-66. PubMed ID: 22520752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers.
    Ashani Y; Gupta RD; Goldsmith M; Silman I; Sussman JL; Tawfik DS; Leader H
    Chem Biol Interact; 2010 Sep; 187(1-3):362-9. PubMed ID: 20303930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
    Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
    FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
    Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents.
    Mata DG; Sabnekar P; Watson CA; Rezk PE; Chilukuri N
    Chem Biol Interact; 2016 Nov; 259(Pt B):233-241. PubMed ID: 27083144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
    Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
    Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase.
    Blum MM; Timperley CM; Williams GR; Thiermann H; Worek F
    Biochemistry; 2008 May; 47(18):5216-24. PubMed ID: 18396898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1.
    Blaha-Nelson D; Krüger DM; Szeler K; Ben-David M; Kamerlin SC
    J Am Chem Soc; 2017 Jan; 139(3):1155-1167. PubMed ID: 28026940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The active site of human paraoxonase (PON1).
    Josse D; Lockridge O; Xie W; Bartels CF; Schopfer LM; Masson P
    J Appl Toxicol; 2001 Dec; 21 Suppl 1():S7-11. PubMed ID: 11920913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
    Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of asymmetric fluorogenic phosphonates as probes for developing organophosphorus hydrolases with broader stereoselectivity.
    Amitai G; Adani R; Limanovich O; Teitlboim S; Yishay S; Tveria L; Yacov G; Meshulam H; Raveh L
    Chem Biol Interact; 2008 Sep; 175(1-3):249-54. PubMed ID: 18588863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
    Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
    Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin.
    Hemmert AC; Otto TC; Wierdl M; Edwards CC; Fleming CD; MacDonald M; Cashman JR; Potter PM; Cerasoli DM; Redinbo MR
    Mol Pharmacol; 2010 Apr; 77(4):508-16. PubMed ID: 20051531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
    Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Characterization of New SsoPox Variant Points to the Dimer Interface as a Driver for the Increase in Promiscuous Paraoxonase Activity.
    Suzumoto Y; Dim O; Roviello GN; Worek F; Sussman JL; Manco G
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro detoxification of cyclosarin in human blood pre-incubated ex vivo with recombinant serum paraoxonases.
    Ashani Y; Goldsmith M; Leader H; Silman I; Sussman JL; Tawfik DS
    Toxicol Lett; 2011 Sep; 206(1):24-8. PubMed ID: 21807078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.